United Kingdom

Sawai Pharmaceutical Co Ltd (4555.T)

4555.T on Tokyo Stock Exchange

17 Nov 2017
Change (% chg)

¥50 (+0.82%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Hiroyuki Sawai

79 2008 Chairman of the Board, Representative Director

Mitsuo Sawai

60 2008 President, Representative Director

Kenzo Sawai

48 2017 Senior Managing Executive Officer, Director of Strategy Planning, Director

Takashi Iwasa

64 2013 Managing Executive Officer, Chief Director of Sales, President of Subsidiary, Director

Minoru Kodama

63 2013 Managing Executive Officer, Chief Director of Administration, Deputy Chief Director of Sales, Director